EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Embecta Corp.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.21−0.06 (-0.96%)

Close on Oct 19, 2026

Market cap: $363.36M
P/E (TTM): 4.2
Dividend yield: 9.66%

Embecta Corp. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30
Revenue	1,080	1,123	1,121	1,130	1,165	1,086
Cost of Revenue	404	388	371	355	365	323
Gross Profit	677	735	750	775	800	763
Research & Development	37	79	85	67	63	61
Selling, General & Admin	332	365	341	295	240	215
Advertising Expenses	16	9.00	16	12	9.30	8.20
Operating Expenses	435	568	528	465	308	276
Operating Income	242	167	222	310	492	487
Interest & Investment Income	6.00	12	9.40	0	0	–
Other Non-Operating Income	1.50	-10	-8.80	-6.80	2.90	-0.70
Merger & Restructuring Charges	38	0	0	–	–	–
Asset Impairment Charges	0	0	2.50	59	0	0
Pretax Income	136	44	106	257	495	486
Income Tax Expense	41	-34	35	33	80	58
Net Income	95	78	70	224	415	428
EPS (Basic)(per share)	1.64	1.36	1.23	3.92	7.28	7.50
EPS (Diluted)(per share)	1.62	1.34	1.22	3.89	7.28	7.50
Shares Outstanding (Basic, Weighted)(shares)	58	58	57	57	57	57
Shares Outstanding (Diluted, Weighted)(shares)	59	58	58	57	57	57
Dividend per Share(per share)	0.60	0.60	0.60	0.15	–	–
EBITDA	283	203	254	341	530	525

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.0%
Operating margin: 21.9%
Net margin: 8.6%
Return on equity, FY2025: -13.7%

Financial strength

Current ratio: 1.68
Debt to equity: -2.37
Debt to assets: 115.0%
Cash to current liabilities: 51.1%

Valuation

P/E ratio: 4.2
Price to sales: 0.36
Price to book: –
Dividend yield: 9.66%